Sign up for our newsletter
All-time Popular Posts
A biobetter trastuzumab is on the way
EGA president calls on Member States to boost market access for biosimilars in the EU
3rd Forum on Biosimilars
Pfizer starts biosimilar rituximab Phase I/II trial
Indian Biosimilars Market
World’s first biosimilar antibody* is approved in Korea
A biosimilar manufacturer: Celltrion
2 patents down, 1 to expire: Herceptin biosimilar coming to EU
Archives
Recent Comments
- Dareen on Celltrion receives approval for Mabthera biosimilar in EU
- Peter Norman on Celltrion receives approval for Mabthera biosimilar in EU
- Alan M Appel on FDA approves Erelzi, a biosimilar to Enbrel
- New Corporate Laws Treatise on 70 stakeholder groups call on the FDA, urging distinguishable, meaningful suffixes for biosimilars
- james harris on Delivering on the Potential of Biosimilar Medicines
Share an Article?
Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.
We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?
Suggestions?
Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!